Earlier this year, I decided to take the plunge and join the board of GenXys Health Care Systems (GenXys) as an independent board member. I have been intrigued by precision medicine for years, wondering why this has been historically slow to catch on. In a...
GenXys, a health tech company focused on pharmacogenetic enhanced prescribing automation software, is pleased to announce that it has closed an oversubscribed seed round at $3 million. Led by Green Shield Canada, (GSC), with key investors including TELUS Ventures, Esplanade Ventures, Nimbus Synergies, and the...
Katie Capps from GTMRx Institute was a guest on our podcast, Precision Insights, and gave listeners an overview on what comprehensive medication management (CMM) is, and how pharmacogenetics can become part of that process. We’ve taken some of the highlights of this episode and put...
At the time of recording, Colleen Keenan was a consultant with Advisory Board’s Clinical Innovators Council, a membership group for researchers designed to help suppliers strengthen their relationships with integrated delivery networks and their providers. Colleen had been with Advisory Board for over four years...
GenXys, a health tech company focused on pharmacogenetic enhanced prescribing automation software, is pleased to announce that it has closed an oversubscribed seed round at $3 million. Led by Green Shield Canada, (GSC), with key investors including TELUS Ventures, Esplanade Ventures, Nimbus Synergies, and the...
The fantastic Sara Rogers of the American Society of Pharmacovigilance (ASP) and the Pharmacogenetics Access and Reimbursement Coalition (PARC) joined us in an episode of Precision Insights to discuss ASP, PARC, and the STRIPE Collaborative Community, which aims to accelerate the development of personalized medicine...
We've got an exciting product release to share with you. This enterprise release of our software extends the capability, interoperability, security, and performance of the most robust and most performant pharmacogenetic (PGx) supported precision prescribing platform on the market. Falling into the wider category of...
When Melissa Badowski came on our podcast, Precision Insights, to talk about her experiences using telehealth, we were very excited to hear about how she uses it to deliver comprehensive medication management, and her tips for delivering telehealth more effectively. ...
Jared spoke with us on the Precision Insights podcast about telehealth, and how it has been affected by the COVID-19 pandemic, along with his predictions for the future of telehealth. What follows is a summary of the discussion we had with him; the full podcast...
Dr. James Lu co-founded population genomics company Helix in 2015, where he leads the research, regulatory policy and bioinformatics teams. He oversees the teams that develop and validate the science and technology behind Helix’s solution, including Helix’s next generation sequencing lab. Dr. Lu also works...
